Source link : https://www.newshealth.biz/health-news/ema-oks-sublingual-formulation-for-opioid-dependence/
The European Medicines Agency has recommended granting marketing authorization for a new hybrid formulation of buprenorphine as a substitution treatment of opioid drug dependence. Buprenorphine Neuraxpharm is available as multiple-strength sublingual films. The Committee for Medicinal Products for Human Use (CHMP) said its recommendation was intended to cover use in adults and adolescents 15 years […]
Author : News Health
Publish date : 2024-10-18 14:55:39
Copyright for syndicated content belongs to the linked Source.
Categories